Showing results (251-260 of 440) with videos related to
Sort By:
Pageof 44
Journal of Thrombosis and Haemostasis : JTH|August 25, 2019
Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono- and dual-antiplatelet therapyKevin Bliden, Rahul Chaudhary, Athan Kuliopulos, et al.Stroke|December 26, 2013
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysisGhazaleh Gouya, Jasmin Arrich, Michael Wolzt, et al.Current Atherosclerosis Reports|October 22, 2013
Pharmacology of antiplatelet agentsKiran Kalra, Christopher J Franzese, Martin G Gesheff, et al.Clinical Pharmacokinetics|April 21, 2012
Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studiesSteen E Husted, Robert F Storey, Kevin Bliden, et al.Journal of the American College of Cardiology|January 18, 2006
Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein levelBarry E Bleske, John M Nicklas, Robert L Bard, et al.Progress in Cardiovascular Diseases|April 6, 2020
Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trialsAakash Garg, Amit Rout, Abhishek Sharma, et al.Korean Circulation Journal|March 3, 2021
Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic DifferencesHyun Kuk Kim, Udaya S Tantry, Hyun Woong Park, et al.Journal of Thrombosis and Thrombolysis|January 24, 2019
"Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute strokeKevin P Bliden, Gabe Raviv, Udaya S Tantry, et al.Journal of Thrombosis and Thrombolysis|January 18, 2022
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomesAbira Usman, Kevin P Bliden, Alastair Cho, et al.JAMA|April 21, 2018
Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysisEliano P Navarese, Jennifer G Robinson, Mariusz Kowalewski, et al.Pageof 44